Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease

doi:10.1016/S0140-6736(00)02246-7

The Lancet

Volume 355, Issue 9216, 13 May 2000, Pages 1696-1697

https://doi.org/10.1016/S0140-6736(00)02246-7 Get rights and content

Summary

In patients with Alzheimer's disease, but not in health controls, longitudinal magnetic resonance spectroscopy shows a striking decline in the neuronal marker, N-acetyl aspartate, despite little decline in underlying grey-matter volume.

References (5)

OAC Petroff et al.
Symbiosis between in vivo and in vitro NMR spectroscopy; the creatine, N-acetylasparate, glutamate and GABA content of the epileptic human brain
Magnetic Resonance Imaging
(1995)
HH Tallan
Studies on the distribution of N-acetyl-L-aspartate acid in brain
J Bid Chem
(1956)

There are more references available in the full text version of this article.

Cited by (0)

View full text

Research LettersLongitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease

Summary

Magnetic Resonance Imaging

Studies on the distribution of N-acetyl-L-aspartate acid in brain

J Bid Chem

Research Letters
Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease